跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 御展
副教授
生物醫學影像暨放射科學系
電話
+886-2-2826-7064
電子郵件
yuchanchang
nycu.edu
tw
h-index
h10-index
h5-index
1751
引文
25
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1750
引文
25
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1023
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2024
每年研究成果
概覽
指紋
網路
研究成果
(82)
類似的個人檔案
(6)
指紋
查看啟用 Yu-Chan Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Lung Cancer
97%
Metastasis
77%
Overexpression
74%
Aldolase
67%
Cholangiocarcinoma
66%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
58%
Poor Prognosis
56%
In Cancer
54%
Glioblastoma
54%
Cancer Progression
45%
Lung Metastasis
42%
Cancer Metastasis
37%
Cancer Cells
35%
Metabolic Reprogramming
35%
Glycolysis
34%
Magnetic Resonance Imaging
32%
Colorectal Cancer
30%
Prognosis Marker
30%
Head-and-neck Cancer
29%
Catenin
28%
Theranostics
28%
Dysregulation
27%
Epithelial-mesenchymal Transition
26%
Molecular Mechanism
26%
Lung Adenocarcinoma
26%
Knockdown
26%
Hypoxia-inducible factor-1α (HIF-1α)
25%
Tumor Cells
25%
Prognostic Factors
24%
Cancer Stemness
23%
FePt
23%
Cancer Types
23%
Cell Growth
22%
Tumorigenesis
22%
Lung Cancer Progression
22%
Lung Cancer Cells
21%
Metabolism
21%
Nanoparticles
21%
Magnetic Resonance Imaging Contrast Agents
20%
In Situ
19%
Therapeutic Targeting
19%
Immune Checkpoint Inhibitors
19%
Tumor
19%
Regorafenib
18%
Iron-platinum Nanoparticles
18%
Methylthioadenosine Phosphorylase
18%
Squalene Synthase
18%
Human Glioma
18%
Osteopontin
18%
Rab GTPase
18%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Carcinogenesis
53%
Aldolase A
46%
Reprogramming
45%
Enzyme
39%
Drug Resistance
33%
Metabolic Pathway
32%
Microarrays
30%
Colon
30%
Messenger RNA
29%
Catenin
28%
Signal Transduction
27%
Survival Rate
27%
Mesenchymal-Epithelial Transition
27%
AMP-activated Protein Kinase
27%
Cell Proliferation
25%
Downregulation
24%
Tamsulosin
24%
Cancer Staging
23%
Fructose-Bisphosphate Aldolase
23%
Actin
22%
Protein Expression
22%
Proteomics
21%
Transcription Factors
21%
Aldolase
20%
Transcriptomics
20%
Cell Growth
20%
Gene Expression
19%
Osteopontin
18%
Follistatin
18%
Phosphorylase
18%
RUNX2
18%
GLUT4
18%
GTPase
18%
Aldolase C
18%
Galactose
18%
Glucose Transporter
18%
Gene Mutation
18%
Epidermal Growth Factor Receptor
18%
Hypoxia Inducible Factor 1
16%
Exocytosis
16%
RNA
16%
STAT3
14%
Cell Migration
14%
Overall Survival
14%
Cell Motility
14%
Mucin
14%
P16
14%
Biological Functions
14%
Interleukin 6
12%
Medicine and Dentistry
Metastatic Carcinoma
99%
Lung Cancer
78%
Malignant Neoplasm
68%
Head and Neck Squamous Cell Carcinoma
44%
Cholangiocarcinoma
37%
Neoplasm
34%
Cancer Growth
33%
Biological Marker
28%
Colorectal Carcinoma
28%
Fructose Bisphosphate Aldolase
27%
Cancer Cell
26%
In Vitro
24%
Cancer Therapy
20%
Magnetic Resonance Imaging
18%
Receptor
18%
Gemcitabine
18%
Oral Cancer
18%
AMP-Activated Protein Kinase
18%
Ganglioglioma
18%
Immune Checkpoint Inhibitor
18%
Carcinogenesis
18%
Cancer
14%
Proteomics
14%
Lymph Node Metastasis
13%
Follistatin
13%
Mouth Squamous Cell Carcinoma
13%
Cancer Staging
13%
Glycolytic Enzyme
13%
Tumor Microenvironment
13%
Combination Therapy
12%
Tumor Cell
12%
Mesenchymal-Epithelial Transition
12%
Gene Mutation
12%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
11%
Downregulation
11%
Tamsulosin
11%
Cytotoxicity
11%
Bladder Cancer
11%
Squamous Cell Carcinoma Cell
10%
Epidermal Growth Factor Receptor
10%
Nanocomposite
10%
Head and Neck Cancer
10%
Reactive Oxygen Species
10%
Non Small Cell Lung Cancer
10%
Carbohydrate Sulfotransferase
10%
Radiation Therapy
10%
Cell Growth
10%
Fibroblast
10%
Glioblastoma
10%
Cancer Stem Cell
10%
